News
Regeneron Inc. seeks to disqualify Kirkland & Ellis from representing its opponent Novartis AG in a major antitrust and ...
Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...
Findings that U.S. companies can sue foreign rivals despite limited business operations in the country could dissuade drug ...
In combination with Eli Lilly’s tirzepatide, marketed as Zepbound for obesity, Scholar Rock’s monolonal antibody helped ...
Scholar Rock said on Wednesday a combination of its experimental drug and Eli Lilly's weight-loss treatment Zepbound helped overweight patients preserve significantly more lean mass in a mid-stage ...
(Reuters) -Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can ...
The ICO has fined 23andMe £2.31 million due to its failures in responding to a 2023 data breach. The UK's data protection watchdog has fined DNA testing company 23andMe £2.31 million for failing to ...
Annual Shareholders Meeting was a governance-heavy affair, with proposals flying faster than a biotech merger rumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results